ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.480
+$0.070 (+2.05%)
Day Range
$3.350 - $3.540
52 Week Range
$0.560 - $5.240
Volume
178.62K
Avg Volume (10D)
633.32K
Market Cap
$550.13M
Price Chart
Market Statistics
Open$3.410
Previous Close$3.410
Day High$3.540
Day Low$3.350
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap550.13M
Shares Outstanding158.08M
Price to Book17.41
Trading Activity
Volume178.62K
Value Traded615.56K
Bid$3.460 × 774
Ask$3.580 × 1,000
Performance
1 Day-3.25%
5 Day-7.37%
13 Week-3.25%
52 Week311.32%
YTD-30.57%
Technical Indicators
RSI (14)39.67
50-Day SMA$3.971
200-Day SMA$2.291
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
